Dr Mauro Biffi (University of Bologna, IT) discusses the Acticor/Rivacor ICD and CRT-D Family with the Plexa ProMRI S DX Lead.
- What were your key observations regarding the implantation procedure with Rivacor devices?
- What are the main benefits of the new Rivacor ICDs and CRT-Ds for your patients?
- Rivacor devices feature BIOTRONIK’s DX Technology. Why do you consider this important?
- What kind of patients would benefit most of this technology?
- You are an investigator of the “Less is More” study. Could you elaborate on it?